Lista de obras - Francesco Cipollone - Dominio Público Uruguay

A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke

artículo científico publicado en 2004

A unique microRNA signature associated with plaque instability in humans

artículo científico publicado en 2011

Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).

artículo científico publicado en 2010

Association between 5-lipoxygenase expression and plaque instability in humans

artículo científico publicado en 2005

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

artículo científico publicado en 2009

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy

artículo científico publicado en 2002

Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.

artículo científico publicado en 2005

Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy.

artículo científico publicado en 2010

Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans

artículo científico publicado en 2004

Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity

artículo científico publicado en 2004

COX-2 and atherosclerosis.

artículo científico publicado en 2006

COX-2 and prostaglandins in atherosclerosis.

artículo científico publicado en 2005

COX-2 and the vasculature: angel or evil?

artículo científico publicado en 2007

COX-2 expression in atherosclerosis: the good, the bad or the ugly?

artículo científico publicado en 2007

Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes

artículo científico publicado en 2002

Cox-2 polymorphisms and cardiovascular disease: elucidating the hidden side of the disease

artículo científico publicado en 2009

Cyclooxygenase and atherosclerosis: a smoking area.

artículo científico publicado en 2010

Cyclooxygenase-2 expression and inhibition in atherothrombosis

artículo científico publicado en 2004

Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk.

artículo científico publicado en 2006

Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury?

artículo científico publicado en 2002

Deoxyribonuclease I: exploring the hidden side of myocardial infarction.

artículo científico publicado en 2006

Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus

artículo científico publicado en 1999

EP receptors and coxibs: seeing the light at the end of the tunnel

artículo científico publicado en 2013

Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease

artículo científico publicado en 2011

Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy

artículo científico publicado en 2005

Effects of nabumetone on prostanoid biosynthesis in humans.

artículo científico publicado en 1995

Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy.

artículo científico publicado en 2004

Endothelial function in sustained and white coat hypertension

artículo científico publicado en 2002

Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decrease

scientific article published on 01 January 2007

Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.

artículo científico publicado en 2006

Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.

artículo científico publicado en 2005

Extremely rare case of vascular dysphagia in an elderly man

artículo científico publicado en 2013

Flow-mediated vasodilation: improving specificity for endothelial function evaluation

artículo científico publicado en 2013

Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective study

artículo científico publicado en 2010

Genetic and molecular determinants of atherosclerotic plaque instability

artículo científico publicado en 2010

Guidelines enforcement and clinical outcome.

artículo científico publicado en 2013

Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques

artículo científico publicado en 2004

Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria

artículo científico publicado en 2001

Laminar shear stress regulates endothelial kinin B1 receptor expression and function: potential implication in atherogenesis

artículo científico publicado en 2009

Letter by Santovito et al regarding article, "rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation".

artículo científico publicado en 2013

Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization

artículo científico publicado en 2020

Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.

artículo científico publicado en 2002

Management of hyperuricemia and gout in obese patients undergoing bariatric surgery

artículo científico publicado en 2018

MicroRNAs and atherosclerosis: new actors for an old movie.

artículo científico

Novel determinants of plaque instability

artículo científico publicado en 2005

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients ⬇️

artículo científico publicado el 23 de enero de 2013

Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.

artículo científico publicado en 2000

Platelets in atherothrombosis: new and evolving roles.

artículo científico publicado en 2007

Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.

artículo científico publicado en 2003

Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels ⬇️

artículo científico publicado el 25 de noviembre de 2011

Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design.

artículo científico publicado en 2012

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.

artículo científico publicado en 2009

Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome.

artículo científico publicado en 2003

Role of angiotensin II receptor blockers in atherosclerotic plaque stability.

artículo científico publicado en 2006

Serum angiogenin concentrations in young patients with diabetes mellitus

artículo científico publicado en 2002

Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes

artículo científico publicado en 2006

Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans

artículo científico publicado en 2003

Targeted quantitative analysis of fatty acids in atherosclerotic plaques by high sensitivity liquid chromatography/tandem mass spectrometry

artículo científico publicado en 2006

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

artículo científico publicado en 2003

Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus

artículo científico publicado en 2006

Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications

scientific article published on 01 September 2000

Lista de obras de Francesco Cipollone

A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke

A unique microRNA signature associated with plaque instability in humans

Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial).

Association between 5-lipoxygenase expression and plaque instability in humans

Association between circulating soluble receptor for advanced glycation end products and atherosclerosis: observations from the Dallas Heart Study.

Association between enhanced soluble CD40L and prothrombotic state in hypercholesterolemia: effects of statin therapy

Association between prostaglandin E receptor subtype EP4 overexpression and unstable phenotype in atherosclerotic plaques in human.

Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy.

Balance between PGD synthase and PGE synthase is a major determinant of atherosclerotic plaque instability in humans

Blockade of the angiotensin II type 1 receptor stabilizes atherosclerotic plaques in humans by inhibiting prostaglandin E2-dependent matrix metalloproteinase activity

COX-2 and atherosclerosis.

COX-2 and prostaglandins in atherosclerosis.

COX-2 and the vasculature: angel or evil?

COX-2 expression in atherosclerosis: the good, the bad or the ugly?

Circulating monocyte chemoattractant protein-1 and early development of nephropathy in type 1 diabetes

Cox-2 polymorphisms and cardiovascular disease: elucidating the hidden side of the disease

Cyclooxygenase and atherosclerosis: a smoking area.

Cyclooxygenase-2 expression and inhibition in atherothrombosis

Cyclooxygenase-2 inhibition: vascular inflammation and cardiovascular risk.

Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury?

Deoxyribonuclease I: exploring the hidden side of myocardial infarction.

Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus

EP receptors and coxibs: seeing the light at the end of the tunnel

Effect of 2-year treatment with low-dose rosuvastatin on intima-media thickness in hypercholesterolemic subjects with asymptomatic carotid artery disease

Effects of irbesartan on intracellular antioxidant enzyme expression and activity in adolescents and young adults with early diabetic angiopathy

Effects of nabumetone on prostanoid biosynthesis in humans.

Effects of vitamin E supplementation on intracellular antioxidant enzyme production in adolescents with type 1 diabetes and early microangiopathy.

Endothelial function in sustained and white coat hypertension

Enhanced plasma soluble CD40 ligand levels in essential hypertensive patients with blunted nocturnal blood pressure decrease

Enhanced soluble CD40 ligand and Alzheimer's disease: evidence of a possible pathogenetic role.

Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.

Extremely rare case of vascular dysphagia in an elderly man

Flow-mediated vasodilation: improving specificity for endothelial function evaluation

Functional rs20417 SNP (-765G>C) of cyclooxygenase-2 gene does not predict the risk of recurrence of ischemic events in coronary patients: results of a 7-year prospective study

Genetic and molecular determinants of atherosclerotic plaque instability

Guidelines enforcement and clinical outcome.

Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques

Increased vascular endothelial growth factor serum concentrations may help to identify patients with onset of type 1 diabetes during childhood at risk for developing persistent microalbuminuria

Laminar shear stress regulates endothelial kinin B1 receptor expression and function: potential implication in atherogenesis

Letter by Santovito et al regarding article, "rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation".

Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization

Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzyme-A inhibitor simvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E.

Management of hyperuricemia and gout in obese patients undergoing bariatric surgery

MicroRNAs and atherosclerosis: new actors for an old movie.

Novel determinants of plaque instability

Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients ⬇️

Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.

Platelets in atherothrombosis: new and evolving roles.

Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.

Proprotein convertase subtilisin kexin type 9 (PCSK9) secreted by cultured smooth muscle cells reduces macrophages LDLR levels ⬇️

Prospective appraisal of the prevalence of primary aldosteronism in hypertensive patients presenting with atrial flutter or fibrillation (PAPPHY Study): rationale and study design.

Receptor for advanced glycation end-products (RAGE) and soluble RAGE (sRAGE): cardiovascular implications.

Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome.

Role of angiotensin II receptor blockers in atherosclerotic plaque stability.

Serum angiogenin concentrations in young patients with diabetes mellitus

Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes

Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans

Targeted quantitative analysis of fatty acids in atherosclerotic plaques by high sensitivity liquid chromatography/tandem mass spectrometry

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus

Vascular endothelial growth factor (VEGF) in children, adolescents and young adults with Type 1 diabetes mellitus: relation to glycaemic control and microvascular complications